% alzhub.org library filter % Source: https://alzhub.org/research?author=Sabbagh+MN&score_min=67 % 8 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{honig2024-38730496, author = {Honig, L. S. and Sabbagh, M. N. and van Dyck, C. H. and Sperling, R. A. and Hersch, S. and Matta, A. and Giorgi, L. and Gee, M. and others}, title = {{Updated safety results from phase 3 lecanemab study in early Alzheimer's disease}}, journal = {Alzheimer's research \& therapy}, year = {2024}, doi = {10.1186/s13195-024-01441-8}, pmid = {38730496}, url = {https://doi.org/10.1186/s13195-024-01441-8} } @article{salloway2018-29914022, author = {Salloway, S. P. and Sperling, R. and Fox, N. C. and Sabbagh, M. N. and Honig, L. S. and Porsteinsson, A. P. and Rofael, H. and Ketter, N. and others}, title = {{Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2018}, doi = {10.3233/jad-171157}, pmid = {29914022}, url = {https://doi.org/10.3233/jad-171157} } @article{rafii2022-35532913, author = {Rafii, M. S. and Sol, O. and Mobley, W. C. and Delpretti, S. and Skotko, B. G. and Burke, A. D. and Sabbagh, M. N. and Yuan, S. H. and others}, title = {{Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical Trial}}, journal = {JAMA neurology}, year = {2022}, doi = {10.1001/jamaneurol.2022.0983}, pmid = {35532913}, url = {https://doi.org/10.1001/jamaneurol.2022.0983} } @article{curtis2015-25622185, author = {Curtis, C. and Gamez, J. E. and Singh, U. and Sadowsky, C. H. and Villena, T. and Sabbagh, M. N. and Beach, T. G. and Duara, R. and others}, title = {{Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density}}, journal = {JAMA neurology}, year = {2015}, doi = {10.1001/jamaneurol.2014.4144}, pmid = {25622185}, url = {https://doi.org/10.1001/jamaneurol.2014.4144} } @article{caselli2009-19605830, author = {Caselli, R. J. and Dueck, A. C. and Osborne, D. and Sabbagh, M. N. and Connor, D. J. and Ahern, G. L. and Baxter, L. C. and Rapcsak, S. Z. and others}, title = {{Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect}}, journal = {The New England journal of medicine}, year = {2009}, doi = {10.1056/nejmoa0809437}, pmid = {19605830}, url = {https://doi.org/10.1056/nejmoa0809437} } @article{galasko2014-24696507, author = {Galasko, D. and Bell, J. and Mancuso, J. Y. and Kupiec, J. W. and Sabbagh, M. N. and van Dyck, C. and Thomas, R. G. and Aisen, P. S. and others}, title = {{Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease}}, journal = {Neurology}, year = {2014}, doi = {10.1212/wnl.0000000000000364}, pmid = {24696507}, url = {https://doi.org/10.1212/wnl.0000000000000364} } @article{sabbagh2011-21192237, author = {Sabbagh, M. N. and Agro, A. and Bell, J. and Aisen, P. S. and Schweizer, E. and Galasko, D.}, title = {{PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease}}, journal = {Alzheimer disease and associated disorders}, year = {2011}, doi = {10.1097/wad.0b013e318204b550}, pmid = {21192237}, url = {https://doi.org/10.1097/wad.0b013e318204b550} } @article{doraiswamy2012-22786606, author = {Doraiswamy, P. M. and Sperling, R. A. and Coleman, R. E. and Johnson, K. A. and Reiman, E. M. and Davis, M. D. and Grundman, M. and Sabbagh, M. N. and others}, title = {{Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study}}, journal = {Neurology}, year = {2012}, doi = {10.1212/wnl.0b013e3182661f74}, pmid = {22786606}, url = {https://doi.org/10.1212/wnl.0b013e3182661f74} }